Share your videos with the world

Sign Up | Log In | Help  

Hint: ClipMoon is not responsible for the content of this page. These contents are from private users!

  Highlights of the RESILIENT Trial  
Average ( 0 votes)
Not yet rated
Please sign up
and login to rate this video.!

C. R. Bard, Inc. today announced the publication of RESILIENT trial results by Circulation: Cardiovascular Interventions showing the Bard LifeStent® Vascular Stent improved patency and reduced revascularization rates in patients with moderate-length lesions in the superficial femoral artery (SFA) and proximal popliteal artery compared to patients treated with percutaneous transluminal angioplasty (PTA). To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bard/44623/
Added on 16-06-2010 by MultiVuVideo

PHP Scripts and Service
 

Video Details //

 
Runtime: 4m15s | Views: 5211 | Comments: 0

Categories:  News and Politics 
 

User Details //

 
Videos: 926 | Favorites: 0 | Friends: 0
User Name:  MultiVuVideo

  Share Details //  
Video URL:  
(E-mail or link it)

Embeddable Player:
(Put this video on your website. Works on Friendster, eBay, Blogger, MySpace and many more sites!)

Thumbnail URL:
Preview:
(Put this thumbnail on your website, blog or in your forum posts.)


Comment on this video:
Comments (0):
Please help keep this site FUN, CLEAN, and REAL.
Please sign up and login to flag or comment this video.!

    
   Other Videos  

< PREV

 
Featured Videos
 
Runtime: 1m48s
Views: 9987
Comments: 1
by adnani
Runtime: 0m44s
Views: 10557
Comments: 0
by yukafo
Runtime: 1m53s
Views: 55
Comments: 1
by tory
Runtime: 2m6s
Views: 491
Comments: 0
Runtime: 0m12s
Views: 13157
Comments: 2
Runtime: 0m11s
Views: 447
Comments: 1
 
PHP Scripts and Custom Service

 

 

About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2022 ClipMoon. All rights reserved.